Myelodysplastic Syndromes: Phase 1 Trial Results Find Potential in New Combination Therapy
According to a story from GlobeNewswire, the biopharmaceutical company Onconova Therapeutics, Inc. has recently published results from a phase 1 clinical trial that was sponsored by the company. This trial…